Stay updated on CTX001 in β-Thalassemia: Safety/Efficacy Clinical Trial
Sign up to get notified when there's something new on the CTX001 in β-Thalassemia: Safety/Efficacy Clinical Trial page.

Latest updates to the CTX001 in β-Thalassemia: Safety/Efficacy Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page footer’s listed “Revision” number has been updated from v3.5.2 to v3.5.3, reflecting a site version change rather than an update to the study record.SummaryDifference0.0%

- Check28 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check56 days agoChange DetectedThe page now lists Revision: v3.5.0, replacing the previous Revision: v3.4.3.SummaryDifference0.0%

- Check70 days agoChange DetectedRevision indicator updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check92 days agoChange Detected- Revision updated from v3.4.1 to v3.4.2.SummaryDifference0.0%

- Check100 days agoChange DetectedRevision notes updated from v3.4.0 to v3.4.1 on the page; this does not affect core study content (eligibility, outcomes, locations). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to CTX001 in β-Thalassemia: Safety/Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTX001 in β-Thalassemia: Safety/Efficacy Clinical Trial page.